The improvement of recombinant antibody production in Chinese Hamster Ovary (CHO) cells is a crucial aspect of biopharmaceutical development. To maximize efficacy, various methods are employed, including molecular engineering of the host cells and optimization of growth conditions. Additionally, integration of advanced fermenters can significantl